Four weight-loss adverts banned for promoting prescription-only medicines

The Advertising Standards Authority banned four adverts from Voy, Juniper and MedExpress, finding that they promoted prescription-only weight-loss medicines to the public. The rulings covered two Voy adverts and one each from Juniper and MedExpress.

• The ASA banned four adverts: two from Voy and one each from Juniper and MedExpress.· 1 source
• The ASA said the Voy adverts’ imagery and wording were likely to make people think they promoted oral Wegovy tablets; small-print references to a food supplement did not change that impression.· 1 source
• The Juniper YouTube advert described a weight-loss pill as available, while MedExpress’s Instagram advert promoted new tablets and invited people to join a waitlist.· 1 source
• The first oral GLP-1 tablet for weight management was licensed as a prescription-only medicine in June; UK rules prohibit advertising prescription-only medicines to the public.· 1 source
• Voy said it withdrew its advert during the investigation and would not run it again. MedExpress said it removed its advert after an internal review.· 1 source